Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank
Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate
Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42% vs 2022
Mauna Kea Technologies Reports 74% Increase in 9-Month 2023 Sales
Mauna Kea Technologies Reports H1 2023 Financial Results
Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue
2022 Universal Registration Document
Mauna Kea Technologies Reports 2022 Annual Results
Mauna Kea Technologies announces the coverage of its stock by Portzamparc – Groupe BNP Paribas
Mauna Kea Technologies Announces Sales for the Fourth Quarter and Full Year 2022
Mauna Kea Technologies Announces its 2023 Financial Calendar
Annual Financial Report 2021
No results found.
News
Mauna Kea Technologies Announces Nomination of 3 New Directors
Publication of the 2025 Annual Financial Report
Mauna Kea Technologies Announces Expanded Clinical Evidence for Cellvizio® To Be Presented at Digestive Disease Week® 2026
No results found.